Skip to main content
. Author manuscript; available in PMC: 2021 Nov 18.
Published in final edited form as: Nat Immunol. 2021 Jul 26;22(8):1020–1029. doi: 10.1038/s41590-021-00979-1

Extended Data Fig. 4.

Extended Data Fig. 4

(A) CCR7 and CD45RA staining on all CD8+ T cells (left) and Flu-specific T cells (right). (B) Venn diagram of ChAR overlap in Flu tet+ cells (bottom) from HCV-infected donors and healthy donors. (C) PD-1 and CD39 staining on tetramer populations before (top) and after (bottom) DAA therapy. (D) Combined principal component analysis of naïve, effector memory, HCV-, and Flu- specific CD8+ T cells from the healthy and HCV cohorts. (E) Heatmap showing pathway enrichment (rows) within clustered ChARs from Figure 4g (columns).